Nizatidine Solution (Gemini Laboratories, LLC)
Welcome to the PulseAid listing for the Nizatidine Solution drug offered from Gemini Laboratories, LLC. This Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Gemini Laboratories, LLC |
| NON-PROPRIETARY NAME: | Nizatidine |
| SUBSTANCE NAME: | NIZATIDINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-08-12 |
| END MARKETING DATE: | 0000-00-00 |
Nizatidine Solution HUMAN PRESCRIPTION DRUG Details:
| Item Description | Nizatidine Solution from Gemini Laboratories, LLC |
| LABELER NAME: | Gemini Laboratories, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 15(mg/mL) |
| START MARKETING DATE: | 2016-08-12 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 60846-301_3a1abd05-b955-1fdd-e054-00144ff8d46c |
| PRODUCT NDC: | 60846-301 |
| APPLICATION NUMBER: | ANDA090576 |
Other NIZATIDINE Pharmaceutical Manufacturers / Labelers:
